Clincosm LogoSign in Get a demo

peripheral t cell lymphoma

Showing 26 - 50 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

Recruiting
  • Cutaneous T Cell Lymphoma
  • Peripheral T Cell Lymphoma
  • Microdevices
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 16, 2022

Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)

Completed
Has Results
  • Peripheral T Cell Lymphoma
  • +18 more
  • Vancouver, British Columbia, Canada
  • +29 more
Apr 29, 2022

Peripheral T Cell Lymphoma Trial in Korea, Republic of, United States (lacutamab)

Recruiting
  • Peripheral T Cell Lymphoma
  • lacutamab
  • Birmingham, Alabama
  • +18 more
Apr 4, 2022

Peripheral T Cell Lymphoma Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 T cells, Bendamustine, Fludarabine)

Recruiting
  • Peripheral T Cell Lymphoma
  • ATLCAR.CD30 T cells
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Mar 4, 2022

Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Nanjing (Chidamide)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • +3 more
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Dec 30, 2021

Peripheral T Cell Lymphoma, Relapse/Recurrence Trial in Belgium, France (Lacutamab, Gemcitabine, Oxaliplatine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Relapse/Recurrence
  • Antwerpen, Belgium
  • +38 more
Dec 6, 2021

Peripheral T Cell Lymphoma Trial in Ann Arbor, Columbus, Madison (Nivolumab, cabiralizumab)

Active, not recruiting
Has Results
  • Peripheral T Cell Lymphoma
  • Ann Arbor, Michigan
  • +2 more
Aug 13, 2021

NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,

Recruiting
  • NK-Cell Lymphoma
  • +2 more
  • San Francisco, California
  • +1 more
Sep 1, 2021

Treatment-naïve, Peripheral T Cell Lymphoma Trial in Guangzhou (Dose-finding stage: Liposomal mitoxantrone HCl,

Recruiting
  • Treatment-naïve
  • Peripheral T Cell Lymphoma
  • Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 26, 2021

Peripheral T Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Anaplastic Lymphoma Trial in Shanghai (anti-TRBC1 CAR-T cell

Recruiting
  • Peripheral T Cell Lymphoma
  • +4 more
  • anti-TRBC1 CAR-T cell therapy
  • Shanghai, Shanghai, China
    Xianmin Song
Mar 31, 2021

Peripheral T Cell Lymphoma Trial in Beijing (GB226)

Recruiting
  • Peripheral T Cell Lymphoma
  • GB226
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 2, 2021

Peripheral T Cell Lymphoma Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome Injection, Chidamide)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Chidamide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 11, 2020

Peripheral T Cell Lymphoma Trial (F520)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • (no location specified)
Oct 19, 2020

Peripheral T Cell Lymphoma Trial in Canton (PLM60)

Withdrawn
  • Peripheral T Cell Lymphoma
  • Canton, Ohio
  • +1 more
Oct 14, 2020

Non-Hodgkin's Lymphoma, Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma, Chronic Lymphoblastic Leukemia Trial in Tianjin

Unknown status
  • Non-Hodgkin's Lymphoma
  • +3 more
  • Autologous γδT cells
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 24, 2019

Peripheral T Cell Lymphoma Trial in Hangzhou (Bortezomib, Etoposide, Cyclophosphamide)

Unknown status
  • Peripheral T Cell Lymphoma
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Aug 18, 2019

Adult T-Cell Lymphoma/Leukaemia, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in Wuhan (Anti-CD30

Recruiting
  • Adult T-Cell Lymphoma/Leukaemia
  • +5 more
  • Anti-CD30 CAR T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 5, 2019

Peripheral T Cell Lymphoma Trial in Hong Kong (cisplatin, ifosfamide, gemcitabine)

Unknown status
  • Peripheral T Cell Lymphoma
  • Hong Kong, Hong Kong
    The University of Hong Kong
Jun 8, 2018

Peripheral T Cell Lymphoma Trial in Shanghai (Chidamide)

Unknown status
  • Peripheral T Cell Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 10, 2017

Peripheral T Cell Lymphoma Trial in Suzhou (Chidamide)

Unknown status
  • Peripheral T Cell Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Aug 30, 2017

Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Australia, United States (Romidepsin)

Completed
Has Results
  • Cutaneous T Cell Lymphoma
  • Peripheral T Cell Lymphoma
  • Scottsdale, Arizona
  • +12 more
Apr 13, 2017

Peripheral T Cell Lymphoma, Progression, Disease Trial in Taipei (Pralatrexate)

Unknown status
  • Peripheral T Cell Lymphoma
  • Progression, Disease
  • Taipei, Taiwan
    Ntional Taiwan University Hospital
May 10, 2017

Peripheral T Cell Lymphoma Trial in Guangzhou (chidamide, cyclophosphamide, liposomal doxorubicin)

Unknown status
  • Peripheral T Cell Lymphoma
  • Guangzhou, Guangdong, China
    Ru Feng
Jan 13, 2017

Peripheral T Cell Lymphoma Trial in Guangzhou (Chidamide)

Unknown status
  • Peripheral T Cell Lymphoma
  • Guangzhou, Guangdong, China
    Guangdong general hospital
Oct 24, 2016

Peripheral T Cell Lymphoma Trial (Chidamide with ICE regimen)

Unknown status
  • Peripheral T Cell Lymphoma
  • Chidamide with ICE regimen
  • (no location specified)
Aug 2, 2016